Infection control and public health aspects of a case of pertussis infection in a maternity health care worker

Authors

  • Bradley J McCall Brisbane Southside Public Health Unit, PO Box 333, Archerfield QLD 4108
  • Martyn Tilse Mater Health Services, South Brisbane, Queensland
  • Beth Burt Mater Health Services, South Brisbane, Queensland
  • Peter Watt Brisbane Southside Public Health Unit, Brisbane, Queensland
  • Mary Barnett Brisbane Southside Public Health Unit, Brisbane, Queensland
  • Joseph G McCormack Mater Health Services, South Brisbane, Queensland; University of Queensland, Department of Medicine and Infectious Diseases, Mater Health Services, South Brisbane, Queensland

DOI:

https://doi.org/10.33321/cdi.2002.26.61

Keywords:

infection control, Pertussis, health care workers

Abstract

The potential for nosocomial outbreaks of pertussis is well recognised. Waning adult immunity to pertussis, failure to recognise the symptoms of adult pertussis infection and delayed introduction of control measures are important contributing factors.1 This report describes the response to a case of pertussis infection diagnosed in a health care worker (HCW) in a busy antenatal/postnatal unit in a large metropolitan hospital and the results of interventions.

Downloads

Download data is not yet available.

References

Weber DJ, Rutala WA. Pertussis: an under-appreciated risk for nosocomial outbreaks. Infect Control Hosp Epidemiol 1998;19:825-828.

McIntyre P, Gidding H, Gilmour R, Lawrence G, Hull B, Hurby P, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. Commun Dis Intell 2002;26 Suppl:43.

National Health and Medical Research Council. The Australian Immunisation Handbook, 7th ed. Canberra: Australian Government Publishing Service, 2000:171.

Smith C, Vyas H, Early infantile pertussis; increasingly prevalent and potentially fatal. Eur J Pediatr 2000;159:898-900.

Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin - Knoxville, Tennessee, 1999. MMWR Morb Mortal Wkly Rep 1999;48:1117-1120.

Honein MA, Paulozzi LJ, Himelright IM, Lee B, Cragan JD, Patterson L, et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet 1999;354:2101-2105.

Mahon BE, Rosenman MB, Kleiman MB. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr 2001;139:380-384.

Communicable Diseases Network Australia New Zealand. The control of pertussis in Australia - November 1997. Communicable Diseases Intelligence Technical Report Series No. 1. Canberra: Commonwealth Department of Health and Family Services, 1998:23.

Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchmann SD. Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1998;19:407-463.

Wright SW, Decker MD, Edwards KM. Incidence of pertussis infection in healthcare workers. Infect Control Hosp Epidemiol 1999;20:120-123.

Gardner P. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations. Clin Infect Dis 1999;28 Suppl 2:S131-S135.

Martinez SM, Kemper CA, Haiduven D, Cody SH, Deresinski SC. Azithromycin prophylaxis during a hospital wide outbreak of a pertussis-like illness. Infect Control Hosp Epidemiol 2001;22:781-783.

Weber DJ, Rutala WA. Pertussis: A continuing hazard for healthcare facilities. Infect Control Hosp Epidemiol 2001;22:736-740

Downloads

Published

31/12/02

How to Cite

McCall, Bradley J, Martyn Tilse, Beth Burt, Peter Watt, Mary Barnett, and Joseph G McCormack. 2002. “Infection Control and Public Health Aspects of a Case of Pertussis Infection in a Maternity Health Care Worker”. Communicable Diseases Intelligence 26 (December):584-86. https://doi.org/10.33321/cdi.2002.26.61.

Issue

Vol. 26 (2002)

Section

Short report

Categories

License

Copyright (c) 2002 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.